CLINICAL TRIAL PACKAGING MARKET

Clinical trial packaging refers to the process of designing, evaluating, and production of packages which helps for enclosing, protecting medicines, distribution, storage, and sales. Packaging of clinical products consists of three major functions which include packaging identification, product protection, and product promotion. Packaging of medicine helps to protect medicines from contamination, damage, degradation, and counter filling are some of the major factors that are positively influencing market growth. Furthermore, cold chain packaging, schedule II (narcotics), patient dosing regimens, supply chain integrity, and among others are positively impacting on the market growth. According to the research studies, clinical trial packaging market is valued at 960.35 million USD in 2016 and is anticipated to reach by 2100.36 million USD by 2026.

Clinical trial packaging market is segmented into material types, packaging types, end users and by region. Based on material types the market is segmented into glass, paper, corrugated fiber, metal, and plastic. Based on packaging the market is classified into tubes, bags, syringes, pouches, ampoules, sachets, blisters, and among others. Based on end users the market is characterized into drug manufacturing facilities, clinical research organization, and research laboratories. Based on region the market is segmented into North America, Europe, Asia Pacific, Middle East, Africa and Latin America.

Technological advancements  such as Smart labels with an integrated (NFC) near-field-communication chips, blow-molding, injection blow-molding and 3D designing software tools  which helps in patient centricity and self growing demand for medication are some of the factors impelling the market growth in near future. Moreover, rise in number of clinical trials, increase in biologics, and rise in bio similar drugs in trails are some of the major driving factors for the market growth during the forecast period. In addition to this, regulatory initiatives have prompted significant change in packaging of clinical trails. For instance, Health Canada recently introduced (PPL) plain packaging language that aim to improve safety and effective use of (OTC) over-the-counter medicines by making outer packaging easier to read and understand. Furthermore, digitization of connecting packaging to mobile phones and introducing of  plastic products for attractiveness, more flexible and economical alternative  to traditional choice of glass packaging are major opportunities that are triggering the  market growth. However, lack of centralized trial registration process across the globe, increase in cost of packaging, lack of trained manpower and stringent regulation are some of the factors hindering the market growth.

Geographically, the market is segmented into North America, Europe, Asia Pacific, Middle East, Africa and Latin America. North America is dominating the market due to well established pharmaceutical industry in the region such as Abbott Laboratories, Abraxis BioScience Inc, ABER Pharmaceuticals, and others.  Regulatory environment for research and development activities are the key factors responsible for the strong growth prospects of the clinical trial packaging market. Developing infrastructure and economic growth in Europe and Asia Pacific are setting up new standards for market growth during forecast period.

Some of the key players in the global clinical trial packaging market include Almac Group, Limited, Bilcare Limited, Catalent, Inc., DMB Consultancy, Fisher Clinical Services Inc, Körber Medipak Systems AG, NextPharma Technologies, PAREXEL International Corporation, PCI Pharma Services, Pharmaterials Ltd, and Piramal Enterprises Ltd, Laboratories, Abraxis BioScience Inc, ABER Pharmaceuticals.

To Learn More about Clinical Trial Course Click